Local view for "http://purl.org/linkedpolitics/eu/plenary/2011-05-10-Speech-2-313-500"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2011-05-10"^^xsd:date2
dcterms:Is Part Of	lp_eu:Explanations of vote2
dcterms:Language	"pt"^^xsd:language2
lpv:document identification number	"en.20110510.60.2-313-500"2
lpv:hasSubsequent	lp_eu:2011-05-10-Speech-2-313-7502
lpv:speaker	lp:Diogo Feio2
lpv:spokenAs	substitute; Delegation to the ACP-EU Joint Parliamentary Assembly (2009-09-16--2014-06-30)3 unknown; Partido Popular (2009-07-14--2014-06-30)3 member; Delegation to the EU-Kazakhstan, EU-Kyrgyzstan and EU-Uzbekistan Parliamentary Cooperation Committees, and for relations with Tajikistan, Turkmenistan and Mongolia (2009-09-16--2014-06-30)3 member; ECON (2009-07-16--2012-01-18)3 member; EPP (2009-07-14--2014-06-30)3 substitute; AFET (2009-07-16--2012-01-18)3 substitute; Special Committee on the Financial, Economic and Social Crisis (2009-10-08--2011-07-31)3
lpv:translated text	"The Joint Undertaking is aimed at the process of developing pharmaceuticals that are more effective and efficient, so that the pharmaceutical sector can produce innovative medicines that are safer and more effective. Therefore, the Joint Undertaking’s objectives are to contribute to the delivery of the Seventh Framework Programme, and to supporting pharmaceutical research and development in Member States, and in countries associated with the Seventh Framework Programme. It encourages participation by small and medium-sized enterprises in its activities, and cooperation between the private sector and universities. It is still at the embryonic stage, so we cannot foresee clearly how its budgeting will be implemented in future. However, it should continue to finish off its internal control and information systems, in particular."@en1

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph